The number of gene partners implied in fusions are highly variable with up to 24 fusion partners identified in ROS-rearranged NSCLC, 48 in RET-rearranged NSCLC and 92 in ALK-rearranged NSCLC12–14. The gene discussed is ALK; the disease is non-small cell lung carcinoma.